Vortioxetine
Year:
subscribe
Notify me when a new related topic is posted
Share page
more »
Edit
Add to rankings
Information

Vortioxetine (trade name Brintellix and Trintellix in Canada) is an atypical antidepressant (a serotonin modulator and stimulator) made by Lundbeck and Takeda. On September 30, 2013, it was approved by the U.S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine was also investigated as a treatment for generalized anxiety disorder (GAD) but was not found to be superior to placebo.

Following a positive opinion by the Committee for Medicinal Products for Human Use (CHMP) in October 2013, Lundbeck announced December 27, 2013, that European marketing authorization for Brintellix had been obtained.

Add your opinion:
Preview:
(mouse over or touch to update)
Item ID:
OK
choose profile
Add your opinion

Forum

1
opinions
0
replies
0
medication for depression
0 votes
Oct 3, 2015

Brintellix is just another dud antidepressant made by Lundbeck. I took it for 3 weeks. Side effects were terrible, the antidepressive effect very doubtful. There is nothing new about this drug. Just another drug poisoning people and bringing money to pharmaceutical companies.

reply
subscribe
share/challenge
flag
Add item to new rankings
or
create new ranking
Add new topic related to Vortioxetine.

Topics

Active
New
Popular
all
today
week
month
year